Clinical Evidence on Starting Doses and Weight Loss Results Clinical trials for semaglutide weight loss therapy typically begin patients at 0.25 mg (approximately 2.5 units) weekly, escalating over 1620 weeks to maintenance doses of 2.4 mg (approximately 12 units) or higher
This focus on ongoing support helps ensure results last beyond the first months of care
doi: 10.1016/j.nut.2018.06.019 58 ZimmerTSDavidBBroekaartDWMSchidlowskiMRuffoloGKorotkovAet al
Always maintain refrigerator temperatures between 3646F
Any potential benefits would likely require integration with dietary modification and physical activity, and neither supplement is recommended in NICE guidance for weight management
Small RCTs suggest benefit for taurine (2 g/day) and branched-chain amino acids (BCAAs), with no significant adverse effects [99,100,101,102,103]